Alaunos Therapeutics, Inc. (TCRT)
Nasdaq: TCRT · CIK 0001107421 · United States
Every official Alaunos Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open TCRT filings
Alaunos Therapeutics, Inc. documents
- Alaunos Therapeutics, Inc. 10-K 2026TCRT 10-K 2026: annual report for fiscal 2026
- Alaunos Therapeutics, Inc. 10-K 2025TCRT 10-K 2025: annual report for fiscal 2025
- Alaunos Therapeutics, Inc. 10-K 2024TCRT 10-K 2024: annual report for fiscal 2024
- Alaunos Therapeutics, Inc. 10-K 2023TCRT 10-K 2023: annual report for fiscal 2023
- Alaunos Therapeutics, Inc. 10-K 2022TCRT 10-K 2022: annual report for fiscal 2022
- Alaunos Therapeutics, Inc. 10-Q 2026TCRT 10-Q 2026: quarterly report for fiscal 2026
- Alaunos Therapeutics, Inc. 10-Q 2025TCRT 10-Q 2025: quarterly report for fiscal 2025
- Alaunos Therapeutics, Inc. 10-Q 2024TCRT 10-Q 2024: quarterly report for fiscal 2024
- Alaunos Therapeutics, Inc. 10-Q 2023TCRT 10-Q 2023: quarterly report for fiscal 2023
- Alaunos Therapeutics, Inc. 10-Q 2022TCRT 10-Q 2022: quarterly report for fiscal 2022
- Alaunos Therapeutics, Inc. 8-K 2026TCRT 8-K 2026: current report for fiscal 2026
- Alaunos Therapeutics, Inc. 8-K 2025TCRT 8-K 2025: current report for fiscal 2025
- Alaunos Therapeutics, Inc. 8-K 2024TCRT 8-K 2024: current report for fiscal 2024
- Alaunos Therapeutics, Inc. 8-K 2023TCRT 8-K 2023: current report for fiscal 2023
- Alaunos Therapeutics, Inc. 8-K 2022TCRT 8-K 2022: current report for fiscal 2022
- Alaunos Therapeutics, Inc. DEF 14A 2026TCRT DEF 14A 2026: proxy statement for fiscal 2026
- Alaunos Therapeutics, Inc. DEF 14A 2025TCRT DEF 14A 2025: proxy statement for fiscal 2025
- Alaunos Therapeutics, Inc. DEF 14A 2024TCRT DEF 14A 2024: proxy statement for fiscal 2024
- Alaunos Therapeutics, Inc. DEF 14A 2023TCRT DEF 14A 2023: proxy statement for fiscal 2023
- Alaunos Therapeutics, Inc. DEF 14A 2022TCRT DEF 14A 2022: proxy statement for fiscal 2022
- Alaunos Therapeutics, Inc. Form 4 2026TCRT Form 4 2026: insider trading filing for fiscal 2026
- Alaunos Therapeutics, Inc. Form 4 2025TCRT Form 4 2025: insider trading filing for fiscal 2025
- Alaunos Therapeutics, Inc. Form 4 2024TCRT Form 4 2024: insider trading filing for fiscal 2024
- Alaunos Therapeutics, Inc. Form 4 2023TCRT Form 4 2023: insider trading filing for fiscal 2023
- Alaunos Therapeutics, Inc. Form 4 2022TCRT Form 4 2022: insider trading filing for fiscal 2022
- Alaunos Therapeutics, Inc. S-1 2026TCRT S-1 2026: registration statement for fiscal 2026
- Alaunos Therapeutics, Inc. S-1 2025TCRT S-1 2025: registration statement for fiscal 2025
- Alaunos Therapeutics, Inc. S-1 2024TCRT S-1 2024: registration statement for fiscal 2024
- Alaunos Therapeutics, Inc. S-1 2023TCRT S-1 2023: registration statement for fiscal 2023
- Alaunos Therapeutics, Inc. S-1 2022TCRT S-1 2022: registration statement for fiscal 2022
- Alaunos Therapeutics, Inc. 13F 2026TCRT 13F 2026: institutional holdings for fiscal 2026
- Alaunos Therapeutics, Inc. 13F 2025TCRT 13F 2025: institutional holdings for fiscal 2025
- Alaunos Therapeutics, Inc. 13F 2024TCRT 13F 2024: institutional holdings for fiscal 2024
- Alaunos Therapeutics, Inc. 13F 2023TCRT 13F 2023: institutional holdings for fiscal 2023
- Alaunos Therapeutics, Inc. 13F 2022TCRT 13F 2022: institutional holdings for fiscal 2022
More companies